Cargando…
Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice
Duchenne muscular dystrophy (DMD) is a lethal muscle disease caused by mutations in the dystrophin gene. CRISPR/Cas9 genome editing has been used to correct DMD mutations in animal models at young ages. However, the longevity and durability of CRISPR/Cas9 editing remained to be determined. To addres...
Autores principales: | Karri, Dileep R., Zhang, Yu, Chemello, Francesco, Min, Yi-Li, Huang, Jian, Kim, Jiwoong, Mammen, Pradeep P.A., Xu, Lin, Liu, Ning, Bassel-Duby, Rhonda, Olson, Eric N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956962/ https://www.ncbi.nlm.nih.gov/pubmed/35402069 http://dx.doi.org/10.1016/j.omtn.2022.03.004 |
Ejemplares similares
-
A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing
por: Zhang, Yu, et al.
Publicado: (2022) -
KLHL41 stabilizes skeletal muscle sarcomeres by nonproteolytic ubiquitination
por: Ramirez-Martinez, Andres, et al.
Publicado: (2017) -
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
por: Chai, Andreas C., et al.
Publicado: (2023) -
Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
por: Caudal, Dorian, et al.
Publicado: (2020) -
Targeted genome editing in vivo corrects a Dmd duplication restoring wild‐type dystrophin expression
por: Maino, Eleonora, et al.
Publicado: (2021)